The Pill may increase the risk of breast cancer according to a large study of younger womenMarch 21, 2002Women who have ever used the Pill face a slightly increased risk of developing breast cancer, according to one of the largest studies on oral contraceptive use, the 3rd European Breast Cancer Conference heard on Friday 22 March. The women's risk rose by just over a quarter (26%) compared with women who had never used the Pill. Women who were still using the Pill had an increased risk of just over a half (58%) compared with never-users. The highest increased risk was amongst women aged 45 or over who were still using the Pill - their risk of developing breast cancer was nearly one and a half times (144%) the risk of never-users. However, Dr Merethe Kumle, the epidemiologist leading the research said that it was important not to over-state this risk. "Oral contraceptives have a lot of advantages as well as disadvantages," she said. "The total number of deaths from any cause amongst women who use oral contraceptives is likely to be lower than women who have never used the Pill - just as we have seen with hormone replacement therapy. The Pill has made it possible for women to decide when and how many children they will give birth to - something which has revolutionised women's lives and is an important issue in women's rights." The study revealed no increased risk among women who used oral contraceptives before the age of 20 or before their first full-term pregnancy. Dr Kumle, from the Institute of Community Medicine in Tromso, Norway, collaborated with researchers in Sweden and France to study data from the "Women's Lifestyle and Health Study" carried out in Norway and Sweden. At the start of 1991/1992, 103,027 women, aged between 30 and 49, completed a questionnaire that included questions on hormonal contraceptive use and other lifestyle characteristics. The researchers followed them through to December 1999 and found that in that time 1,008 cases of breast cancer had been detected. Most of the women who had taken the Pill, had used the more modern brands that are currently prescribed by doctors. Dr Kumle said: "I think the results from this study of Norwegian and Swedish women are very interesting and confirm results from earlier studies of oral contraceptive use. Although the rate of women participating in the study was not very high at 55%, our follow-up is complete and the women we were studying were relatively young. It is clear that oral contraceptives increase a woman's risk of developing breast cancer, particularly when they are used in the later period of reproductive life. "It is important to remember that the absolute risk of a woman developing breast cancer under the age of 40 is very low. Modern oral contraceptives have much lower hormone doses in them than the older ones which did cause an unacceptably high number of adverse effects. "The incidence of breast cancer in Western countries has been increasing in the past 30 years, but there appear to be a number of reasons for this. The use of oral contraceptives is one reason, but girls tending to start their periods earlier, women having fewer and later births, later menopause and overweight after the menopause are all reasons too. "We found a slightly increased risk of breast cancer among users of the Pill, but it is important to underline that young women using the Pill are not playing hazard with their health. As contraception, the Pill should still be the drug of choice for young women." MW Communications |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||